These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12175751)

  • 21. Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.
    Ghaffari A; Navaee K; Oskoui M; Bayati K; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2007 Aug; 67(1):175-86. PubMed ID: 17346954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
    Wulff R; Leopold CS
    Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of Optimum Combination of Eudragit RS/Eudragit RL/Ethyl Cellulose Polymeric Free Films Based on Experimental Design for Using as a Coating System for Sustained Release Theophylline Pellets.
    Akhgari A; Tavakol A
    Adv Pharm Bull; 2016 Jun; 6(2):219-25. PubMed ID: 27478784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-traditional plasticization of polymeric films.
    Wu C; McGinity JW
    Int J Pharm; 1999 Jan; 177(1):15-27. PubMed ID: 10205601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanical properties of dry and wet cellulosic and acrylic films prepared from aqueous colloidal polymer dispersions used in the coating of solid dosage forms.
    Bodmeier R; Paeratakul O
    Pharm Res; 1994 Jun; 11(6):882-8. PubMed ID: 7937530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
    Kaur K; Kim K
    Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.
    Wulff R; Leopold CS
    AAPS PharmSciTech; 2016 Apr; 17(2):493-503. PubMed ID: 26265188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of EUDRAGIT® RS on the release behaviour of theophylline solid dispersions].
    Orugun O; Oyi A; Olowosulu A; Apeji Y; Olayemi O
    Ceska Slov Farm; 2016; 65(6):226-231. PubMed ID: 28079388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
    Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A
    Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of in vitro and in vivo dissolution of theophylline from film-coated pellets.
    Muskó Z; Pintye-Hódi K; Gáspár R; Pintye J; Szabó-Révész P; Eros I; Falkay G
    Eur J Pharm Biopharm; 2001 Mar; 51(2):143-6. PubMed ID: 11226821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissolution behaviour of sustained release formulations of indomethacin with Eudragit RS.
    Khanfar MS; Salem MS; Najib NM; Pillai GK
    Acta Pharm Hung; 1997 Nov; 67(6):235-9. PubMed ID: 9423295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An organic acid-induced sigmoidal release system for oral controlled-release preparations.
    Narisawa S; Nagata M; Danyoshi C; Yoshino H; Murata K; Hirakawa Y; Noda K
    Pharm Res; 1994 Jan; 11(1):111-6. PubMed ID: 8140040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quaternary polymethacrylate-magnesium aluminum silicate films: Water uptake kinetics and film permeability.
    Rongthong T; Sungthongjeen S; Siepmann F; Siepmann J; Pongjanyakul T
    Int J Pharm; 2015 Jul; 490(1-2):165-72. PubMed ID: 26004005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug release mechanism of famotidine time-controlled release pellets].
    Zhang L; Chen DW; Gao ZB
    Yao Xue Xue Bao; 2006 Sep; 41(9):873-7. PubMed ID: 17111836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of substitution of plasticizer dibutyl phthalate with dibutyl sebacate on Eudragit
    Chaudhary RS; Patel T; Kumar JR; Chan M
    Pharm Dev Technol; 2019 Mar; 24(3):276-282. PubMed ID: 29688126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA; Basit AW
    Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs.
    Goto S; Kawata M; Nakamura M; Nagatsuma Y; Fujinaga K; Aoyama T
    J Microencapsul; 1988; 5(4):343-60. PubMed ID: 3236155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.